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Résumé en
anglais
Assessment of anti-tumor treatment efficiency is usually done by measuring tumor
size. Treatment may however induce changes in the tumor other than tumor size.
Magnetic Resonance Imaging Texture Analysis (MRI-TA) is presently used to follow
activated lymphocyte cell therapy. We used a 7T microimager to acquire high-
resolution MR images of an experimental liver metastasis from colon carcinoma in
rats treated (n = 4) or not (n = 3) with a cell therapy product. MRI-TA was then
performed with Linear Discriminant Analysis and showed: i) a significant variation
of tumor texture with tumor growth and ii) a significant modification in the texture
of tumors treated with activated lymphocytes compared with untreated tumors. T2-
weighted images or volume calculation did not evidence any difference. MRI-TA
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